KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medpace Holdings (MEDP) Non-Current Debt (2016 - 2022)

Medpace Holdings' Non-Current Debt history spans 6 years, with the latest figure at $249.7 million for Q2 2022.

  • For Q2 2022, Non-Current Debt changed N/A year-over-year to $249.7 million; the TTM value through Jun 2022 reached $249.7 million, changed N/A, while the annual FY2018 figure was $79.7 million, 61.13% down from the prior year.
  • Non-Current Debt reached $249.7 million in Q2 2022 per MEDP's latest filing, up from $55.8 million in the prior quarter.
  • In the past five years, Non-Current Debt ranged from a high of $249.7 million in Q2 2022 to a low of $55.8 million in Q1 2019.
  • Average Non-Current Debt over 3 years is $137.8 million, with a median of $130.4 million recorded in 2018.
  • Peak YoY movement for Non-Current Debt: increased 22.98% in 2018, then crashed 69.19% in 2019.
  • A 3-year view of Non-Current Debt shows it stood at $79.7 million in 2018, then crashed by 30.03% to $55.8 million in 2019, then skyrocketed by 347.64% to $249.7 million in 2022.
  • Per Business Quant, the three most recent readings for MEDP's Non-Current Debt are $249.7 million (Q2 2022), $55.8 million (Q1 2019), and $79.7 million (Q4 2018).